Effects of donor-specific transfusion, cyclosporine a and FK 506 on rat cardiac allograft survival
Davies, C.B.; Cofer, B.R.; Alexander, J.W.
Transplantation Proceedings 23(6): 3314-3315
1991
ISSN/ISBN: 0041-1345 PMID: 1721448 Document Number: 384797
Document emailed within 1 workday
Related Documents
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181Schulak, J.A.; Cooke, J.C.; Herrmann, M.J. 1990: Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts Transplantation 50(2): 341-343
Choti, M.; Lenrow, D.; Roza, A.; Markmann, J.; Naji, A. 1989: Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells Transplantation Proceedings 21(1 Pt 1): 478-479
Goss, J.A.; Nakafusa, Y.; Yu, S.; Flye, M.W. 1993: Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection Transplantation Proceedings 25(1 Part 1): 286-288
Farges, O.; Buffello, D.; Shi, Y.M.; Moufetier, A.; Bismuth, H. 1995: Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine a Transplantation Proceedings 27(4): 2525-2527
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364
Ringers, J.; Haanstra, K.G.; Kroczek, R.A.; Kliem, K.; Kuhn, E.M.; Wubben, J.; Ossevoort, M.A.; Volk, H.Dieter.; Jonker, M. 2002: Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates Transplantation 73(6): 862-866
Jaskłowska-Englisz, M.; Olszewski, W.L. 1994: Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected Transplantation Proceedings 26(6): 3463
Hillis, A.N.; Duguid, J.; Evans, C.M.; Bone, J.M.; Sells, R.A. 1987: Three year experience of donor specific transfusion and concomitant cyclosporine a Transplantation Proceedings 19(1 Part 3): 2248-2249
Okazaki, H.; Takahashi, H.; Miura, K.; Ishizaki, M.; Taguchi, Y. 1984: Significant reduction of sensitization and improved allograft outcome with donor-specific buffy coat transfusion Transplantation 37(5): 523-525
Lenrow, D.A.; Markmann, J.F.; Shachner, M.S.; Naji, A. 1989: Prolongation of cardiac allograft survival by suppressor T cells (Ts) generated in vitro using cyclosporine Transplantation Proceedings 21(1 Part 1): 473-474
Romaniuk, A.; Ryffa, T.; Rowiński, W.; Olszewski, W.L. 1989: Prolongation of heart allograft survival in course of donor specific antigen and alloserum treatment in the rat Archivum Immunologiae et Therapiae Experimentalis 37(3-4): 253-260
Kamei, T.; Callery, M.P.; Flye, M.W. 1990: Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival Surgery 108(2): 415
Mottram, P.L.; Mirisklavos, A.; Clunie, G.J. 1985: Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts Transplantation Proceedings 17(2): 1646-1649
Greenstein, S.M.; Sun, S.C.; Senitzer, D.; Schechner, R.S.; Tellis, V.A. 1993: Pretreatment with irradiation and donor-specific transfusion prolongs survival in small intestinal transplantation Transplantation Proceedings 25(1 Part 1): 490-491
Oluwole, S.F.; Fawwaz, R.A.; Reemtsma, K.; Hardy, M.A. 1988: The role of suppressor T lymphocytes in the induction of specific immunologic unresponsiveness to rat cardiac allografts by donor leukocytes and cyclosporine Transplantation Proceedings 20(3 Suppl 3: 1038-1044
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1996: Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion Transplantation Proceedings 28(6): 3269
Bordes-Aznar, J.; Odor, A.; Dib-Kuri, A.; Gabilondo, F.; Kasep, J.; Peña, J.C.; Herrera-Acosta, J.; Chávez-Peón, F. 1987: Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation Transplantation Proceedings 19(1 Pt 3): 2276-2277
Racelis, D.; Martinelli, G.P.; Schanzer, H. 1984: Effects of antithymocyte serum on cardiac allograft survival in thymectomized-splenectomized rats Mount Sinai Journal of Medicine new York 51(3): 262-267
Sheil, A.G.; Disney, A.P.; Mathew, T.H.; Amiss, N.; Excell, L. 1991: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA Transplantation Proceedings 23(1 Part 2): 1111-1112